BioSpace News Archive

Kastle Systems announced today that it is providing property owners, tenants and employees with a new ability to add vaccination status as a factor to control access to offices and buildings, an important step in helping workers get back to the office safely.

Urology of San Antonio, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure

Future Market Insights: The growing awareness about early detection of dermatological fungal diseases and a vast base of geriatrics are key factors driving onychomycosis treatment revenues and research

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the company has awarded a Technology Access Program grant with Illumina Accelerator startup, Doloromics, focused on gaining a deeper understanding of chronic pain diseases by spatially characterizing the dorsal root ganglion (DRG)

Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a leading clinical-stage company focused on developing regenerative medicine therapeutics company, today announced that Dr. Philip Toleikis, President and CEO will present live at LifeSciencesInvestorForum.com on March 25 th . DATE: Thursday, March 25 th TIME: 10:30am ET

Tikcro Technologies Ltd. (OTC: TIKRF) today announced that its Board of Directors has decided to take steps required to distribute the company’s net cash to its shareholders.

An ANDS is an application to Health Canada to approve a prescription generic pharmaceutical for sale in Canada.

Scripps Health, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure.

Researchers at The Feinstein Institutes for Medical Research , in collaboration with Columbia University, have identified a gene mutation that could result in schizophrenia, a chronic brain disorder that affects nearly one percent of the world’s population .

FDA Authorizes use of BPM31510 in Neo-Adjuvant and Concurrent Standard of Care Combination in Newly Diagnosed GBM Patients in a Phase 2 Clinical Trial